Regional differences in self-reported screening, prevalence and management of cardiovascular risk factors in Switzerland
Open Access
- 28 March 2012
- journal article
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 246
- https://doi.org/10.1186/1471-2458-12-246
Abstract
In Switzerland, health policies are decided at the local level, but little is known regarding their impact on the screening and management of cardiovascular risk factors (CVRFs). We thus aimed at assessing geographical levels of CVRFs in Switzerland. Swiss Health Survey for 2007 (N = 17,879). Seven administrative regions were defined: West (Leman), West-Central (Mittelland), Zurich, South (Ticino), North-West, East and Central Switzerland. Obesity, smoking, hypertension, dyslipidemia and diabetes prevalence, treatment and screening within the last 12 months were assessed by interview. After multivariate adjustment for age, gender, educational level, marital status and Swiss citizenship, no significant differences were found between regions regarding prevalence of obesity or current smoking. Similarly, no differences were found regarding hypertension screening and prevalence. Two thirds of subjects who had been told they had high blood pressure were treated, the lowest treatment rates being found in East Switzerland: odds-ratio and [95% confidence interval] 0.65 [0.50-0.85]. Screening for hypercholesterolemia was more frequently reported in French (Leman) and Italian (Ticino) speaking regions. Four out of ten participants who had been told they had high cholesterol levels were treated and the lowest treatment rates were found in German-speaking regions. Screening for diabetes was higher in Ticino (1.24 [1.09 - 1.42]). Six out of ten participants who had been told they had diabetes were treated, the lowest treatment rates were found for German-speaking regions. In Switzerland, cardiovascular risk factor screening and management differ between regions and these differences cannot be accounted for by differences in populations' characteristics. Management of most cardiovascular risk factors could be improved.Keywords
This publication has 29 references indexed in Scilit:
- Using spatial analysis to demonstrate the heterogeneity of the cardiovascular drug-prescribing pattern in TaiwanBMC Public Health, 2011
- Variations in cardiovascular disease under-diagnosis in England: national cross-sectional spatial analysisBMC Cardiovascular Disorders, 2011
- Exploring the disparities of regional health care expenditures in Switzerland: some empirical evidenceThe European Journal of Health Economics, 2011
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)European Heart Journal, 2011
- EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countriesEuropean Journal of Preventive Cardiology, 2010
- Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus studyEuropean Journal of Preventive Cardiology, 2009
- Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in EnglandJournal of Epidemiology and Community Health, 2004
- Geographical differences in blood pressure of male youth aged 17–21 years in ChinaBlood Pressure, 2004
- Awareness, treatment and control of hyperliidaemia in middle-aged men in France and Northern Ireland in 1991-1993Acta Cardiologica, 2002
- Private finance initiativeBMJ, 2000